Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
140.00    -1.25 (-0.88%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £109.86m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Scheduled Trading Statement

15 Dec 2016 07:00

RNS Number : 8880R
Xaar PLC
15 December 2016
 

15 December 2016

 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar", "the Group" or "the Company"), the digital inkjet printing technology Group headquartered in Cambridge, UK, announces an update on trading for the period beginning 1 July 2016. 

The Board now expects total revenue in the second half of 2016 to be similar to the £44.5 million recorded in the first six months of the year, before taking account of revenue delivered by the acquired EPS business which contributed to the Group from 1 July 2016. The Board's expectation for overall full year earnings remains unchanged.

In ceramic tile printing ("Ceramics"), initial demand for Xaar's new 2001 and 2001+ printheads is strong following the launch of those products in September. Longer than expected customer printer re-designs and manufacturing ramp up, combined with the competitive pressures we have previously highlighted in this sector, are expected to result in lower Ceramics sales in the second half of 2016 than previously anticipated. The products launched this year position the Company well in terms of maintaining Xaar's market leading position and supporting our OEM partners in 2017 and beyond.

In Packaging and Product Printing, sales are ahead of expectations. All packaging sub-sectors, including labels, coding & marking and direct to shape, are delivering organic growth ahead of both H1 2016 and H2 2015 sales. Engineered Printing Solutions ("EPS"), the US product printing equipment company acquired on 1 July 2016, is performing to plan and a smooth integration into the Xaar Group has been achieved.

Initial demand is high from our partner OEMs for the new Thin Film printheads launched this year, the 5601 and the 1201. Both products are on track to provide significant revenue contributions in 2017.

Revenue from Xaar's licensing business has again been strong in the second half of 2016, through a combination of favourable exchange rates, higher licensee royalties and a significant royalty audit resolution. Royalty related revenue in the second half of 2016 is therefore expected to be similar to the total recorded in the first six months of the year.

The Company expects to announce its 2016 full year results on 22 March 2017.

This announcement has been determined to contain inside information.

Contacts

 

Xaar plc

Alex Bevis, CFO

+44 (0)1223-423663

Doug Edwards, CEO

www.xaar.com

Tulchan Communications

James Macey White

 

+44 (0)20-7353-4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDZLFFQLFXFBX
Date   Source Headline
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.